Soc. Generale Call 50 OMV 19.09.2.../ DE000SY62ES1 /
1/10/2025 8:54:40 AM | Chg.0.000 | Bid9:03:07 AM | Ask9:03:07 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.013EUR | 0.00% | 0.014 Bid Size: 35,000 |
0.024 Ask Size: 35,000 |
OMV AG | 50.00 EUR | 9/19/2025 | Call |
GlobeNewswire
3/26/2024
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
1/16/2024
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
9/14/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
GlobeNewswire
12/4/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
12/4/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center